HomeNewsTrendsEntertainmentAfter COVID-19 impact, is box office slowly on its way to be back in black?

After COVID-19 impact, is box office slowly on its way to be back in black?

A Hollywood venture and a south film is helping Indian box office get its charm back.

December 27, 2020 / 14:08 IST
Story continues below Advertisement
The film is slated to release on December 23. Wonder Woman 1984 has seen many delays and change in release schedules due to closure of theatres because of coronavirus-led lockdown across the globe. (Image: Twitter)
The film is slated to release on December 23. Wonder Woman 1984 has seen many delays and change in release schedules due to closure of theatres because of coronavirus-led lockdown across the globe. (Image: Twitter)

After staying dried up for months due to coronavirus-led lockdown, box office is slowly seeing cash registers ringing thanks to Hollywood and some regional content from down south.

While Hollywood's big venture Wonder Woman 1984 (WW84) is taking away all the limelight, a recently released Telugu film, Solo Brathuke So Better is doing wonders down south especially in markets like Andhra Pradesh and Telangana.

Story continues below Advertisement

The film in these two markets alone has collected around Rs 8 crore in two days of its release in cinemas. Considered as the first big Telugu film to release in theatres after the lockdown, Solo Brathuke So Better released in cinemas on December 25 and earned around Rs 4 crore on its opening day.

The romantic-comedy drama maintained its growth momentum in terms of box office collections on its second day and took its two day total to around Rs 8 crore in two markets alone.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show